Latest news with #Grifols
Business Wire
4 days ago
- Business
- Business Wire
Mason Capital Management to Support Grifols Recommended Director Slate at Upcoming Ordinary General Meeting
NEW YORK--(BUSINESS WIRE)--Mason Capital Management LLC ('Mason'), a registered investment advisor to funds and accounts holding approximately 3% of Grifols S.A. ('Grifols' or the 'Company') (BME: GRF) (NASDAQ: GRFS) class A shares, today announced that it sent a letter to the Grifols Board of Directors (the 'Board') expressing Mason's support for the Company's recommended slate of director candidates for election at the Ordinary General Shareholders' Meeting to be held on June 4 and 5, 2025. The full text of the letter follows: Grifols, S.A. Avinguda de la Generalitat 152-158 08174 Sant Cugat del Vallès Barcelona – SPAIN Dear Grifols Board Members: Mason Capital owns ~3% of Grifols A shares. We are aligned with the current Board and are supportive of the recommended slate of director candidates for election at the AGM. We appreciate the constructive dialogue with Board members to date, particularly Tomas Daga, the retiring Thomas Glanzmann, and the incoming chairwoman Anne Berner. Grifols has amalgamated world class assets over its long history and benefits from an excellent management team that is executing on an achievable 5-year plan. Mason believes board leadership continuity and continued management focus will lead to a much higher stock price over time, as more long-only investors engage with Grifols shares. Regards, Kenneth M Garschina Managing Member Mason Capital Management About Mason Capital Management LLC Mason Capital Management LLC is an absolute return focused investment firm that combines deep fundamental analysis with hard catalysts to drive value creation. Founded in July 2000 by Ken Garschina and Mike Martino, Mason's strategies range from event-driven investing to corporate carve-outs and control acquisitions.
Yahoo
4 days ago
- Business
- Yahoo
US court finds enough evidence to proceed with Grifols lawsuit against Gotham City
MADRID (Reuters) -A New York court found enough evidence to continue with the defamation lawsuit filed by Spanish pharmaceutical company Grifols against short seller Gotham City Research, Grifols said in a statement on Friday. Based on its findings, the Federal District Court for the Southern District of New York rejected a request filed by Gotham City to dismiss the lawsuit, Grifols said. In January 2024, Gotham, which had previously shorted Grifols shares, released a report accusing the company of overstating earnings and understating debt. Grifols denied the allegations but lost around a third of its market value following the report. Shorting involves borrowing shares in order to sell them, with the hope of buying them back more cheaply to make a profit. According to Grifols, the court also found that Grifols adequately argued that Gotham City's report contained false statements, such as that the company had failed to disclose a $95 million loan to Scranton Enterprises. Gotham City did not immediately respond to a request for comment.
Yahoo
4 days ago
- Business
- Yahoo
US court finds enough evidence to proceed with Grifols lawsuit against Gotham City
MADRID (Reuters) -A New York court found enough evidence to continue with the defamation lawsuit filed by Spanish pharmaceutical company Grifols against short seller Gotham City Research, Grifols said in a statement on Friday. Based on its findings, the Federal District Court for the Southern District of New York rejected a request filed by Gotham City to dismiss the lawsuit, Grifols said. In January 2024, Gotham, which had previously shorted Grifols shares, released a report accusing the company of overstating earnings and understating debt. Grifols denied the allegations but lost around a third of its market value following the report. Shorting involves borrowing shares in order to sell them, with the hope of buying them back more cheaply to make a profit. According to Grifols, the court also found that Grifols adequately argued that Gotham City's report contained false statements, such as that the company had failed to disclose a $95 million loan to Scranton Enterprises. Gotham City did not immediately respond to a request for comment. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Reuters
4 days ago
- Business
- Reuters
US court finds enough evidence to proceed with Grifols lawsuit against Gotham City
MADRID, May 30 (Reuters) - A New York court found enough evidence to continue with the defamation lawsuit filed by Spanish pharmaceutical company Grifols ( opens new tab against short seller Gotham City Research, Grifols said in a statement on Friday. Based on its findings, the Federal District Court for the Southern District of New York rejected a request filed by Gotham City to dismiss the lawsuit, Grifols said. In January 2024, Gotham, which had previously shorted Grifols shares, released a report accusing the company of overstating earnings and understating debt. Grifols denied the allegations but lost around a third, opens new tab of its market value following the report. Shorting involves borrowing shares in order to sell them, with the hope of buying them back more cheaply to make a profit. According to Grifols, the court also found that Grifols adequately argued that Gotham City's report contained false statements, such as that the company had failed to disclose a $95 million loan to Scranton Enterprises. Gotham City did not immediately respond to a request for comment.
Yahoo
4 days ago
- Business
- Yahoo
US court finds enough evidence to proceed with Grifols lawsuit against Gotham City
MADRID (Reuters) -A New York court found enough evidence to continue with the defamation lawsuit filed by Spanish pharmaceutical company Grifols against short seller Gotham City Research, Grifols said in a statement on Friday. Based on its findings, the Federal District Court for the Southern District of New York rejected a request filed by Gotham City to dismiss the lawsuit, Grifols said. In January 2024, Gotham, which had previously shorted Grifols shares, released a report accusing the company of overstating earnings and understating debt. Grifols denied the allegations but lost around a third of its market value following the report. Shorting involves borrowing shares in order to sell them, with the hope of buying them back more cheaply to make a profit. According to Grifols, the court also found that Grifols adequately argued that Gotham City's report contained false statements, such as that the company had failed to disclose a $95 million loan to Scranton Enterprises. Gotham City did not immediately respond to a request for comment.
